Category: Company News
-

Zhibao Technology Signs NEXSYS Acquisition Agreement for Planned AI Computing Infrastructure Business
Zhibao Technology (NASDAQ:ZBAO) agreed to acquire newly incorporated Malaysian company NEXSYS TECH, with up to $7.5 million of share-based consideration tied to audited profit targets from a planned AI computing infrastructure business. Key Investor Takeaways Why ZBAO Stock Is in Focus Zhibao Technology has signed a definitive agreement to acquire all outstanding shares of NEXSYS…
-

Kandi Technologies Reports 57.4% First-Half Revenue Growth as Net Income Reaches $9.4 Million
Kandi Technologies (NASDAQ:KNDI) reported first-half 2026 revenue growth alongside a return to operating profitability, while expanding into battery swapping and AI data center backup power. Key Investor Takeaways Why KNDI Stock Is in Focus Kandi Technologies reported first-half 2026 net revenue of $57.1 million, a 57.4% increase from $36.3 million in the comparable period of…
-

VisionWave Highlights STRATUM Autonomous Ground Systems Platform for Multi-Mission Defense Operations
VisionWave’s STRATUM architecture covers four modular unmanned ground platforms in development, but none has completed qualification testing, entered production, secured customer sales or generated revenue. Key Investor Takeaways Why VWAV Stock Is in Focus VisionWave (NASDAQ:VWAV) has outlined its STRATUM autonomous ground systems architecture, comprising the VARAN, RANGER, SCOUT and RECON unmanned ground platforms. All…
-

Kraig Biocraft Laboratories Completes Project Atlas Gene Library for Next-Generation Spider Silk Development
Kraig Biocraft Laboratories (USOTC:KBLB) has completed the foundational Project Atlas Gene Library after integrating all planned transgenes into living commercial silkworm hosts, moving the research program into breeding and evaluation of more than 200 potential genetic configurations. Key Investor Takeaways Why KBLB Stock Is in Focus Kraig Biocraft Laboratories has completed the foundational Gene Library…
-

Bell Buckle Holdings Completes Las Vegas Venue Buildout Ahead of Planned Public Opening
Bell Buckle Holdings (USOTC:BLLB) has completed construction and remodeling of its new two-floor Las Vegas Boulevard venue, moving the project into a phased opening that is expected to begin with a soft launch next week. Key Investor Takeaways Why BLLB Stock Is in Focus Bell Buckle Holdings has completed construction and remodeling of its new…
-

IonQ Superion 256 Platform Selected by Florida International University for First Florida Deployment
IonQ (NYSE:IONQ) has secured a contract to install its 256-qubit Superion quantum computer at Florida International University, marking the first sale and planned deployment of the system in Florida and expanding IonQ’s on-premises academic footprint. Key Investor Takeaways Why IONQ Stock Is in Focus IonQ has signed a contract with Florida International University to deploy…
-

NEXT10 Binding LOI Targets Approximately 75% Ownership of BitFrontier Capital Holdings
NEXT10 (USOTC:NXTN) has signed a binding letter of intent with BitFrontier Capital Holdings (USOTC:BFCH), doing business as UNLOCKD, for a staged strategic transaction that could ultimately give NEXT10 approximately 75% ownership of BFCH. Key Investor Takeaways Why NXTN and BFCH Stocks Are in Focus NEXT10 has entered into a binding LOI with BFCH outlining a…
-

Sky Quarry Restarts Eagle Springs Refinery After Receiving Nevada Air Permit
Sky Quarry (NASDAQ:SKYQ) has restarted Nevada’s only crude oil refinery following regulatory approval and approximately $300,000 of repairs and upgrades, with the company now focused on ramping operations toward the facility’s 5,000-barrel-per-day nameplate capacity. Key Investor Takeaways Why SKYQ Stock Is in Focus Sky Quarry has restarted its Eagle Springs Refinery near Ely, Nevada, after…
-

Profusa ISO 13485 Certification Decision Advances Lumee Oxygen Platform Toward CE Mark
Profusa received a positive decision from GMED on ISO 13485 certification, expected in early October, while additional European MDR conformity assessment work remains before the Lumee Oxygen Platform can receive a CE mark. Key Investor Takeaways Why PFSA Stock Is in Focus Profusa has received a positive decision from GMED regarding ISO 13485 certification of…
-

aTyr Pharma FDA Alignment Sets Protocol for Phase 3 Efzofitimod Study in Pulmonary Sarcoidosis
aTyr Pharma plans to begin study-related activities in the fourth quarter of 2026 after reaching FDA alignment on a global Phase 3 efzofitimod trial, although further development will require additional capital. Key Investor Takeaways Why ATYR Stock Is in Focus aTyr Pharma has reached agreement with the FDA on the protocol for its planned Phase…